positive
5h agoTop 3 Pharma Stocks to Watch as India’s Exports Cross $30 Billion

India’s pharmaceutical exports crossed US$ 30 billion in FY25, a significant milestone for the industry. With this surge, pharma stocks are expected to benefit, particularly those engaged in global exports. Aurobindo Pharma, Marksans Pharma, and Gland Pharma are three stocks to watch as they continue to lead the charge in exports. Aurobindo Pharma, with its strong presence in the U.S., remains a top performer, while Marksans Pharma benefits from growth in the U.S. and UK markets. Gland Pharma, focusing on complex injectables, is poised for continued innovation and expansion.
Companies:
- Aurobindo Pharma
- Marksans Pharma
- Gland Pharma
Tags:
- Aurobindo Pharma
- Marksans Pharma
Explore:Mutual Fund Screening
positive
5h agoTop 3 Pharma Stocks to Watch as India’s Exports Cross $30 Billion

India’s pharmaceutical exports crossed US$ 30 billion in FY25, a significant milestone for the industry. With this surge, pharma stocks are expected to benefit, particularly those engaged in global exports. Aurobindo Pharma, Marksans Pharma, and Gland Pharma are three stocks to watch as they continue to lead the charge in exports. Aurobindo Pharma, with its strong presence in the U.S., remains a top performer, while Marksans Pharma benefits from growth in the U.S. and UK markets. Gland Pharma, focusing on complex injectables, is poised for continued innovation and expansion.
Companies:
- Aurobindo Pharma
- Marksans Pharma
- Gland Pharma
Tags:
- Aurobindo Pharma
- Marksans Pharma
Explore:Mutual Fund Screening
1 min read
90 words

Aurobindo Pharma, Marksans Pharma, and Gland Pharma are poised for growth as India’s pharmaceutical exports exceed $30 billion, with strong global demand supporting them.
India’s pharmaceutical exports crossed US$ 30 billion in FY25, a significant milestone for the industry. With this surge, pharma stocks are expected to benefit, particularly those engaged in global exports. Aurobindo Pharma, Marksans Pharma, and Gland Pharma are three stocks to watch as they continue to lead the charge in exports. Aurobindo Pharma, with its strong presence in the U.S., remains a top performer, while Marksans Pharma benefits from growth in the U.S. and UK markets. Gland Pharma, focusing on complex injectables, is poised for continued innovation and expansion.

India’s pharmaceutical exports crossed US$ 30 billion in FY25, a significant milestone for the industry. With this surge, pharma stocks are expected to benefit, particularly those engaged in global exports. Aurobindo Pharma, Marksans Pharma, and Gland Pharma are three stocks to watch as they continue to lead the charge in exports. Aurobindo Pharma, with its strong presence in the U.S., remains a top performer, while Marksans Pharma benefits from growth in the U.S. and UK markets. Gland Pharma, focusing on complex injectables, is poised for continued innovation and expansion.
Companies:
- Aurobindo Pharma
- Marksans Pharma
- Gland Pharma
Tags:
- Aurobindo Pharma
- Marksans Pharma
- Aurobindo Pharma
- Marksans Pharma
- Gland Pharma
- Pharmaceutical Exports
- India Pharma
- Stock Watch
Dec 19, 2025 • 10:15